Research > ETFs > ETF / ETP Commentary > 

Schwab Ramps Up Competition With 4 New ETF Fee Cuts

On Thursday, June 11, Schwab Asset Management announced that it cut down the expense ratios on four of its existing indexed ETFs. Each of these funds is a longstanding strategy in Schwab’s collection, with a significant asset base and compelling track record. As such, these new lower fees amplify the contest between Schwab and its top competitors.Key Takeaways: Schwab Asset Management has lowered the net expense ratios for four of its longstanding passively managed ETFs. These lower fees can help Schwab better compete with other firms on the market that are offering alternative products. That being said, fees are not everything, and the differences in portfolio composition could be more important than saving a few basis points from a lower expense ratio. “Schwab is proud to leverage our growth and efficiencies to drive down costs for investors to better help them achieve their investment goals,” Nicohl Bogan, director of product strategy and development, Schwab Asset Management said. “With today’s fee reductions, building a diversified, index-based portfolio is more cost-effective than ever before with Schwab index ETFs.” First up is the Schwab U.S. Mid-Cap ETF (SCHM A+). Formerly operating with an expense ratio of four basis points, SCHM now only charges three.  Those looking to move further down the cap spectrum might be interested in the Schwab U.S. Small-Cap ETF (SCHA A). Much like SCHM, this small-cap fund has seen its expense ratio drop from four basis points to three. See More: 2026 ETF Inflows: Who Is Leading the Group? Meanwhile, the Schwab International Small-Cap Equity ETF (SCHC A) takes a global approach to small-cap exposure. SCHC’s expense ratio has lowered from eight basis points to six.  Last but certainly not least is the Schwab Emerging Markets Equity ETF (SCHE A-). While it used to have an expense ratio of seven basis points, SCHE is now operating with six. Stepping Up the CompetitionThese newly discounted funds are positioned to better help Schwab compete with other compelling funds in the field. For instance, SCHE’s lower expense ratio puts the fund three basis points below the iShares Core MSCI Emerging Markets ETF (IEMG A). However, fees are not everything. For instance, there are crucial differences within the holdings between IEMG and SCHE, such as SCHE’s significant tilt towards South Korean equities. This is why it’s important for advisors and investors to look at a fund’s specific approach, and not just fixate on the price.  See More: Going for Growth? Consider a Concentrated Approach The same is true for SCHM, the newly-discounted Schwab midcap ETF. The discount now puts the fund at the same price as the Vanguard Mid-Cap ETF (VO B). However, these funds hold different sector concentrations. As of April 30, 2026, VO leans heavily into the industrials, consumer discretionary, and financials sectors. Meanwhile, as of March 31, 2026, SCHM focuses on industrials, informational technology, and financials as its top three sectors. Again, this is why research and due diligence is always more important than choosing the cheapest fund — though a discount is undeniably attractive. A proven provider of exchange-traded funds, Schwab has 34 ETFs listed in the United States. These funds represent more than $570 billion in assets under management.  For more news, information, and analysis, visit the Equity ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.